Levalbuterol or levosalbutamol
- Level
- Commodity
- Parent
- 51391700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51391723This classification denotes a bronchodilator and beta-adrenergic agonist with the molecular formula C13H21NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EDN2NBH5SS, chemically known as 1,3-benzenedimethanol, alpha(sup 1)-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, (-)- but generally known as levalbuterol, which bears US NIH Compound Identifier 123600. European Medicines Agency schedules Levosalbutamol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08491MIG. The term LEVOSALBUTAMOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). Levalbuterol or levosalbutamol bears US NLM identifiers UMLS ID C0772501 and NCI Concept Code C74196. SMILES: CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.
Same parent
Under 51391700 · 48Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.